Following in the footsteps of blockbuster drugs such as Ozempic and Wegovy—both powered by semaglutide—Mounjaro (approved for ...

It’s also sometimes prescribed off-label for weight loss ... Costs can vary and can add up, especially because you may take Mounjaro for an extended period. For a rough idea, Mounjaro can ...

The program included five pivotal trials, which evaluated the efficacy and safety of Mounjaro as a monotherapy, and as an add-on to standard ... SURPASS-2 was an open label, 40-week, phase-3 ...

Around 5 million American women have PCOS, which plays into weight, reproductive health, and fertility outcomes. Here's possible new help.

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and investors breathe easier. Are you reluctant to invest in stocks right now?

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Many investors are bullish on the business because of its highly popular GLP-1 drugs, Mounjaro (approved ... clinical trials that could add important label expansions. Two of these potential ...

The spray container requires no priming—you just insert and press—and its 30 ... to build on its lucrative GLP-1 franchise of Mounjaro and Zepbound. To compete against online compounders ...

Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...